UBS AM’s Acacia Research ACTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-907
Closed -$4.83K 2795
2024
Q1
$4.83K Buy
+907
New +$3.78K ﹤0.01% 2517
2016
Q2
Sell
-20,698
Closed -$78K 2607
2016
Q1
$78K Sell
20,698
-600
-3% -$2.2K ﹤0.01% 2590
2015
Q4
$91K Hold
21,298
﹤0.01% 2660
2015
Q3
$193K Hold
21,298
﹤0.01% 2506
2015
Q2
$187K Buy
21,298
+1,000
+5% +$10.3K ﹤0.01% 2599
2015
Q1
$217K Buy
20,298
+1,000
+5% +$13K ﹤0.01% 2448
2014
Q4
$327K Buy
19,298
+2,100
+12% +$36.4K ﹤0.01% 2175
2014
Q3
$266K Hold
17,198
﹤0.01% 2213
2014
Q2
$305K Hold
17,198
﹤0.01% 2168
2014
Q1
$263K Hold
17,198
﹤0.01% 2264
2013
Q4
$250K Buy
17,198
+200
+1% +$3.16K ﹤0.01% 2255
2013
Q3
$392K Hold
16,998
﹤0.01% 1906
2013
Q2
$380K Buy
+16,998
New +$427K ﹤0.01% 1842

Other funds holding ACTG

UBS AM's ACTG Position: Q2 2024 in Review

UBS AM sold out of Acacia Research (ACTG) in Q2 2024, closing a stake of 907 shares — an estimated $4.83K sold.

UBS AM first reported a position in ACTG in Q2 2013 and held it in 13 quarters. The position peaked at $392K in Q3 2013. 103 funds tracked by Wall St. Rank hold ACTG as of Q2 2024.

  • UBS AM reported no remaining Acacia Research position as of Q2 2024 after selling out during the quarter.
  • UBS AM sold 907 Acacia Research shares in Q2 2024, an estimated $4.83K.
  • UBS AM first reported a position in Acacia Research in Q2 2013 and held it in 13 quarters.
  • UBS AM's Acacia Research position peaked at $392K in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Acacia Research as of Q2 2024.

Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.